<DOC>
	<DOCNO>NCT01407770</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x ray kill tumor cell . Radiation therapy may cause skin reaction patient expose high-energy x ray . Studying genetic pattern patient radiation therapy may help doctor prevent toxicity plan best treatment . PURPOSE : This clinical trial study genetic susceptibility radiation-induced skin reaction racial/ethnic group patient breast cancer .</brief_summary>
	<brief_title>Genetic Susceptibility Radiation-Induced Skin Reactions Racial/Ethnic Groups Patients With Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To develop validate prediction biomarkers radiation therapy ( RT ) -induced acute chronic skin reaction quality life five racial/ethnic group breast cancer patient , Whites* , Black/African Americans , Hispanic/Latinos , Asians/Native Hawaiians/Pacific Islanders , American Indians/Alaskan Natives . NOTE : *This stratum close April 25 , 2012 . - To develop polygenic model RT-induced skin reaction comprehensive evaluation genome-wide nonsynonymous single nucleotide polymorphism ( nsSNPs ) . - To evaluate level DNA damage ( Comet assay ) radiosensitivity ( Cell Cycle G2 Delay assay ) lymphocytes RT . - To test effect gene-gene gene-smoking interaction RT-induced skin reaction . - To assess race-ethnic difference RT-induced skin reaction , DNA damage , radiosensitivity determine gene effect consistent across race-ethnicity ( gene-race/ethnic interaction ) . OUTLINE : This multicenter study . Patients stratify accord race/ethnicity ( Whites* v Black/African Americans vs Hispanic/Latinos v Asians/Native Hawaiians/Pacific Islanders vs American Indians/Alaskan Natives ) . NOTE : *This stratum close April 25 , 2012 . Patients undergo adjuvant radiotherapy breast-conserving surgery . Blood urine sample collect baseline last day radiotherapy genotyping , DNA damage , cell cycle assay , urine cotinine , inflammatory immune response biomarkers , tumor-killing activity BeadArray System , Comet assay , flow cytometry-based assay , Cell-Cycle G2 Delay Assay , Oxygen Radical Absorbance Capacity ( ORAC ) assay , ELISA . Patients assess acute toxicity research staff use ONS Criteria Radiation-Induced Acute Skin Toxicity baseline , week 3 , 1 2 month radiotherapy . Patients also assess chronic toxicity research staff use Chronic skin toxicity questionnaire ( RTOG SOMA Criteria RT- Induced Breast/Chest Wall Late Skin Toxicity ) 6 12 month completion radiotherapy . Photographs breast , chest wall , contralateral breast also take baseline , week 3 , last day radiotherapy , 1 , 2 , 6 , 12 month completion radiotherapy . Patients complete Breast Cancer Risk Study Questionnaire , Functional Assessment Cancer Therapy Breast ( FACT-B ) , Modified Skindex , B39 Quality-of-Life ( QOL ) Questionnaire baseline , last day radiotherapy , 1 , 2 , 6 , 12 month radiotherapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Skin Abnormalities</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Female patient newly diagnose breast carcinoma include ductal carcinoma situ ( DCIS ) Stage 0IIIA disease Status postlumpectomy , quadrantectomy , mastectomy Plan receive adjuvant radiation whole breast chest wall and/or regional lymph nod No site send blood/urine specimen Wake Forest overnight ( next day ) express ship PATIENT CHARACTERISTICS : *This stratum close April 25 , 2012 . No patient understand English unable complete form assistance PRIOR CONCURRENT THERAPY : Total dose &gt; 40 Gy , dose per fraction &gt; 1.8 2.0 Gy , use 2D , 3Dconformal , intensitymodulated radiation therapy ( IMRT ) treatment technique allow ; daily fraction 2.7 Gy whole breast suggest hypofractionated regimen Concurrent sequential boost technique allow standard hypofractionated regimen Adjuvant hormonal therapy allow prior , , and/or radiotherapy ( RT ) discretion medical oncologist Targeted therapy , Herceptin , allow prior , , and/or RT discretion medical oncologist No prior radiation involve breast chest wall No concurrent chemotherapy No patient underwent breast reconstruction follow mastectomy Placement tissue expanders implant allow No patient undergone MammoSiteÂ® form brachytherapy well treat skinsparing IMRT Patients may concurrently enrol protocol involve treatment skin , i.e. , apply lotions/moisturizers Protocols involve treatment skin allow</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>radiation toxicity</keyword>
	<keyword>skin reaction secondary radiation therapy</keyword>
	<keyword>pain</keyword>
	<keyword>fatigue</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>depression</keyword>
	<keyword>cognitive/functional effect</keyword>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>ductal breast carcinoma situ</keyword>
</DOC>